Corepeptides are the functional hearts of a large and growing family of natural products made by bacteria, archaea, and other microorganisms. Each one starts life as a longer precursor protein built on the ribosome, then gets chemically sculpted by enzymes that install rings, cross-links, and other modifications into a specific stretch of amino acids called the core peptide. Once the guiding “leader” region of the precursor is trimmed away, what remains is the mature corepeptide, a small molecule with a constrained three-dimensional shape that can kill rival bacteria, disrupt cell membranes, or serve as a chemical signal. The chemistry hiding in these tiny peptides has drawn serious attention from drug hunters, ecologists, and synthetic biologists alike.
The Precursor Blueprint
Nearly every corepeptide traces back to a single gene encoding a precursor peptide. That precursor is split conceptually into two zones. The leader peptide sits at the front end and acts as a molecular address label, docking with the biosynthetic enzymes and telling them where and how to work. The core peptide sits at the back end and is the raw material that will be chemically modified into the final product.1PubMed Central. Follow the leader: the use of leader peptides to guide natural product biosynthesis This two-part architecture is a defining feature of what researchers call ribosomally synthesized and post-translationally modified peptides, or RiPPs. Because the core peptide is genetically encoded, even single-nucleotide mutations can swap one amino acid for another and generate a completely different product without any change to the enzymatic machinery.
The leader peptide does not appear in the final molecule. Its job is to recruit the right enzymes, hold the precursor in place, and sometimes dictate the order of chemical modifications. In lasso peptide biosynthesis, for instance, one protein in the enzyme complex specifically recognizes the leader sequence, and a second protein then cleaves it off after the core has been processed.2PubMed. Structural Basis of Leader Peptide Recognition in Lasso Peptide Biosynthesis Pathway This separation of recognition and catalysis is a recurring theme across many corepeptide families.
The Many Ways to Remove the Leader
Once the enzymes have finished decorating the core peptide, the leader has to go. The strategies organisms use for this step are remarkably varied. Some systems rely on a single dedicated protease that cuts the leader off in one stroke. Others use two proteases working in tandem, one making an initial cut and the second trimming the remaining stub. Still others depend on a single protease that first cleaves internally and then chews away leftover residues like an aminopeptidase.3PubMed Central. Proteases Involved in Leader Peptide Removal during RiPP Biosynthesis Where the cleavage happens also differs: sometimes inside the cell, sometimes during export through the membrane, and sometimes entirely outside the cell after the precursor has already been secreted.
A striking example of this versatility comes from a class of corepeptides called lanthipeptides. The class III lanthipeptide NAI-112 uses a zinc-dependent protease called AplP that handles both the initial internal cut and the aminopeptidase trimming, a dual function not seen elsewhere in lanthipeptide biosynthesis at the time of its discovery.4PubMed Central. Zn-dependent bifunctional proteases are responsible for leader peptide processing of class III lanthipeptides The diversity in leader removal underscores a broader point: even steps that might seem like housekeeping tasks can carry real biochemical novelty and have been reinvented multiple times in evolution.
Structural Families and What Makes Them Different
Corepeptides fall into structurally distinct families depending on what chemical modifications the biosynthetic enzymes install. Three of the best-studied families illustrate the range.
Lanthipeptides
Lanthipeptides get their name from the unusual amino acids lanthionine and methyllanthionine, which form sulfur-containing cross-links (thioether bridges) within the core peptide. The process starts when certain serine and threonine residues in the core are dehydrated. Cysteine residues then attack those dehydrated sites, forging the cross-links that constrain the peptide into a rigid, polycyclic shape.5PubMed Central. Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes The result is a molecule locked into a specific conformation that often gives it potent biological activity.6PubMed Central. Structure and mechanism of lanthipeptide biosynthetic enzymes
The number and positions of these bridges vary widely. A computational analysis of one lanthipeptide, amyA, found a 29-amino-acid core peptide with five dehydration events and three thioether bridges linking specific serine, threonine, and cysteine residues at defined positions along the chain.7PubMed Central. LanthMS: A Computational Tool for the Structure Elucidation of Lanthipeptides from Tandem Mass Spectrometry Data Each unique bridging pattern creates a different molecular topology and, often, a different biological function.
Lasso Peptides
Lasso peptides adopt one of nature’s most distinctive molecular shapes: a tail threaded through a ring, forming a structure reminiscent of a lariat knot. The ring is typically formed by a bond between the amino terminus of the core peptide and the side chain of an aspartate or glutamate residue several positions downstream, and the remaining C-terminal tail threads through that ring and is trapped by bulky side chains acting as “plugs.” Research on the well-known lasso peptide MccJ25 has shown that the threaded form is actually metastable before the ring closes, meaning the peptide can readily unfold into unthreaded conformations if the ring does not form quickly enough. De novo lasso folding in the absence of biosynthetic assistance appears to be rare.8PubMed Central. Lasso Peptides: Exploring the Folding Landscape of Nature’s Smallest Interlocked Motifs This mechanical interlocking makes lasso peptides exceptionally stable against heat, proteases, and chemical degradation.
Microviridins
Microviridins take a different approach to macrocyclization altogether. Produced by cyanobacteria, their cage-like structures are built through three consecutive macrocyclization reactions catalyzed by two enzymes from a family called ATP-grasp ligases. This enzyme strategy is unique among RiPPs and produces architecturally complex molecules that function as potent, reversible inhibitors of proteases.9PubMed Central. Structural basis for precursor protein-directed ribosomal peptide macrocyclization
When the Core Peptide Itself Guides Modification
A long-held assumption was that biosynthetic enzymes recognize only the leader peptide and pay no attention to the core sequence they modify. That picture has become more complicated. In some systems, the core peptide itself plays an active role in directing which modifications take place. A clear example comes from a class of hypermodified peptides in which one enzyme, CcaM, functions as a dehydratase but only acts on a core peptide that has already undergone a prior modification (azole formation). In other words, the modification state of the core peptide determines whether the next enzyme can do its job.10Nature Communications. Core-dependent post-translational modifications guide the biosynthesis of a new class of hypermodified peptides This core-dependent logic adds another layer of biochemical regulation and means the order of modification events can matter just as much as the enzymes involved.
Killing Bacteria by Targeting the Cell Wall
Many corepeptides, especially lanthipeptides, are potent antibiotics. Their primary target in bacterial cells is a molecule called lipid II, an essential building block of the bacterial cell wall. By binding lipid II, these peptides block the cell wall construction process, which is lethal for a growing bacterium. Some lanthipeptides go further: the well-known lantibiotic nisin, for example, not only sequesters lipid II but also uses the bound lipid II molecule as an anchor to punch holes directly through the bacterial membrane.11PubMed Central. Towards the Native Binding Modes of Antibiotics that Target Lipid II This dual killing mechanism, simultaneously blocking cell wall synthesis and forming pores, makes it extremely difficult for target bacteria to evolve resistance. Other lipid II-binding peptides, such as teixobactin, additionally bind precursors of wall teichoic acids, adding yet another mode of attack.12Journal of Chemical Theory and Computation. Lipid II Binding and Transmembrane Properties of Various Antimicrobial Lanthipeptides
This multi-pronged approach is one reason corepeptide-based antibiotics have attracted so much interest in the era of antimicrobial resistance. Peptides that simultaneously target more than one essential process give bacteria fewer escape routes. When a drug hits a single protein target, a single mutation can confer resistance. But when the drug attacks a lipid building block through multiple mechanisms, resistance requires multiple simultaneous changes, which is orders of magnitude less likely.
Beyond antibacterial uses, antimicrobial peptides in general are being explored for antiviral and anticancer activity. These short amino acid sequences, typically six to fifty residues long, can disrupt cell membranes, modulate immune responses, or target processes inside cells.13PubMed Central. Antimicrobial peptides for anticancer and antiviral therapy: last promising update Marine organisms are a particularly rich source: peptides isolated from sponges, ascidians, and mollusks, including compounds like aplidine and kahalalide F, have shown potent cytotoxic activity against cancer cell lines.14PubMed Central. Marine bioactive peptides with anticancer potential, a narrative review
Chemical Signaling and Ecological Roles
Not every corepeptide is a weapon. Some function as communication molecules, helping microorganisms coordinate behavior through a process called quorum sensing. The oral bacterium Streptococcus mutans, for example, produces a 21-amino-acid signaling peptide that coordinates genetic competence, biofilm formation, and stress responses across the population. Structural analysis of this peptide revealed at least two functional domains: a C-terminal motif of polar, hydrophobic, and charged residues crucial for activating signal transduction, and a core helical structure needed for binding the receptor. Shortening the C-terminus by three or more residues destroyed the signaling ability but actually turned the truncated peptide into a competitive inhibitor that could block quorum sensing by the full-length version.15PubMed Central. Structure-activity analysis of quorum-sensing signaling peptides from Streptococcus mutans
Perhaps even more surprising, some signaling peptides work across species boundaries. The Escherichia coli toxin-antitoxin module mazEF requires a quorum-sensing peptide called extracellular death factor (EDF) to trigger cell death. Researchers discovered that peptides found in the culture supernatants of unrelated organisms, the Gram-positive Bacillus subtilis and the Gram-negative Pseudomonas aeruginosa, could trigger mazEF-mediated death in E. coli despite having completely different amino acid sequences from E. coli‘s own EDF. Each of these interspecies peptides amplified the enzymatic activity of the E. coli toxin, likely by interacting with different binding sites on the same protein.16PubMed Central. Novel quorum-sensing peptides mediating interspecies bacterial cell death This kind of cross-talk suggests that corepeptide signaling in natural environments is far more interconnected than simple species-specific messaging.
Finding New Corepeptides Through Genome Mining
The sequencing revolution has made it clear that microbial genomes encode vastly more corepeptides than have been isolated in the lab. The challenge is identifying the relevant gene clusters buried among thousands of other genes. Several computational approaches have emerged to address this. One early strategy, used by a tool called RiPPquest, combines genomic data with mass spectrometry results: it narrows the search space to genes near known biosynthetic markers and then matches predicted peptide masses against experimental spectra.17PubMed Central. Automated Genome Mining of Ribosomal Peptide Natural Products
A parallel approach focuses specifically on the precursor peptide itself. Because lasso peptide precursors share only a handful of conserved amino acids, a pattern-matching algorithm designed to catch those minimal signatures proved capable of identifying lasso peptide gene clusters that homology-based searches would miss entirely.18PubMed Central. Precursor-centric genome-mining approach for lasso peptide discovery Machine learning has pushed things further still. The tool RiPPMiner, trained on over 500 experimentally verified RiPPs, achieved high sensitivity and specificity for identifying and classifying precursor peptides, though its ability to predict exactly where the leader gets cleaved was less reliable. A newer tool, DeepRiPP, employs deep neural networks and transfer learning for classification, reflecting a general trend toward increasingly powerful computational discovery.19Synthetic and Systems Biotechnology. Challenges and advances in genome mining of ribosomally synthesized and post-translationally modified peptides (RiPPs)
How Corepeptide Structures Are Solved
Determining the exact three-dimensional structure of a corepeptide is nontrivial, especially when the molecule is small, heavily modified, and cyclic. Mass spectrometry is the workhorse tool: it can determine amino acid sequences and characterize modifications like dehydration, thioether bridging, and glycosylation with high sensitivity and speed.20PubMed. Overview of peptide and protein analysis by mass spectrometry For lanthipeptides specifically, tandem mass spectrometry combined with computational tools like LanthMS can predict the positions of dehydration events and thioether bridges from fragmentation patterns, as was demonstrated for the amyA lanthipeptide described earlier.7PubMed Central. LanthMS: A Computational Tool for the Structure Elucidation of Lanthipeptides from Tandem Mass Spectrometry Data
NMR spectroscopy and molecular dynamics simulations complement mass spectrometry by providing information about three-dimensional shape and backbone flexibility. In studies of synthetic macrocyclic peptides formed via Diels-Alder cycloaddition, NMR confirmed that specific ring-closing reactions imparted significant rigidity to the peptide backbone, which in turn improved protease resistance and boosted biological activity.21PubMed Central. Versatile Peptide Macrocyclization with Diels-Alder Cycloadditions Structure elucidation in this field is iterative: mass spectrometry identifies what modifications are present, NMR pins down the spatial arrangement, and computational modeling fills in the dynamic picture.
Pharmacokinetic Hurdles for Corepeptide-Based Drugs
Getting a corepeptide from the lab bench into a patient faces a universal pharmacological problem: peptides, even heavily modified ones, tend to be broken down quickly in the body. Unmodified peptides undergo extensive proteolytic cleavage, resulting in short half-lives in the bloodstream. Low membrane permeability and susceptibility to degradation by digestive enzymes mean that oral bioavailability is usually negligible. With few exceptions, the oral bioavailability of peptide-based drugs is less than one percent, primarily because of enzymatic degradation and pH-mediated hydrolysis in the gastrointestinal tract.22Signal Transduction and Targeted Therapy. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines As a result, most therapeutic peptides on the market are administered by injection, whether intravenous, subcutaneous, or intramuscular, though nasal delivery is used in some cases.23PubMed. Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides
Corepeptides have a partial built-in advantage here. Their macrocyclic and cross-linked structures make them inherently more resistant to protease attack than simple linear peptides. The constrained backbone geometry that arises from thioether bridges, lasso threading, or Diels-Alder cyclization reduces the number of protease-accessible sites. Still, “more resistant” is not the same as “orally available,” and significant engineering is needed to turn most natural corepeptides into practical drugs.
Engineering and Synthetic Advances
One of the most promising aspects of corepeptide biology is the modularity of the biosynthetic system. Because the leader peptide is the part the enzyme recognizes and the core peptide is the part that gets modified, swapping in a different core sequence while keeping the same leader can, in principle, generate an entirely new product. Research has shown that leader-binding domains in lasso peptide biosynthesis rely on a minimal number of hydrophobic interactions and a conserved binding motif. A single leader-binding domain can engage sequence-divergent leader peptides as long as that motif is present, and non-natural peptides carrying the motif also bind with low micromolar affinity. This portability opens avenues for creating semisynthetic hybrid products by mixing and matching leaders and cores from different organisms.24PubMed Central. Steric complementarity directs sequence promiscuous leader binding in RiPP biosynthesis
On the purely synthetic side, automated peptide synthesis platforms have reached a level of sophistication where complex modifications can be carried out in a single uninterrupted protocol on one machine. A recently developed system demonstrated lipidation, ring-closing metathesis, copper-catalyzed click chemistry, cysteine arylation, directed oxidative folding, and native chemical ligation as part of a fully programmable workflow.25Nature Communications. Universal peptide synthesis via solid-phase methods fused with chemputation This kind of automation could drastically speed up the production and testing of corepeptide analogs, especially when combined with computational predictions about which analogs are most likely to be biologically active.
Self-Immunity and the Producer’s Dilemma
If a bacterium makes a peptide that kills other bacteria by punching holes in their membranes, it faces an obvious problem: how does it avoid killing itself? Producer organisms solve this with dedicated immunity systems. These typically involve specialized membrane transporters from the ATP-binding cassette (ABC) family that pump the toxic peptide out of the cell as it is made, along with immunity proteins that sit in the membrane and block pore formation from the inside.26PubMed. Self-immunity to antibacterial peptides by ABC transporters Understanding these self-protection mechanisms is practically important for bioengineering: if you want to produce a potent antimicrobial corepeptide in a new host organism, you need to co-express the right immunity machinery, or the host will simply die.
Corepeptides Beyond Bacteria
For decades, corepeptide research focused almost exclusively on bacteria, and to a lesser extent on cyanobacteria and fungi. Archaea, the third domain of life, were largely overlooked. That changed with a recent deep survey of archaeal genomes, which uncovered 24 previously unknown lanthipeptides through the first application of heterologous expression in archaeal natural product discovery. Among these were lanthipeptides with a distinctive structural feature: diamino-dicarboxylic termini not seen in their bacterial counterparts. More intriguingly, these archaeal lanthipeptides showed antagonistic activity against haloarchaea and a newly described ecological function: enhancing the producer’s motility by inducing a change in cell shape from irregular to rod-like and boosting the expression of genes needed for swimming-like movement.27PubMed Central. Decoding the Chemical Language of Ribosomally Synthesized and Post-Translationally Modified Peptides from the Untapped Archaea Domain The idea that a corepeptide can directly change the physical shape and behavior of the organism producing it adds an entirely new dimension to the ecological roles these molecules play.
Evolutionary Flexibility of Core Peptide Sequences
One of the most remarkable features of corepeptide systems is the evolutionary disconnect between the enzymes and their substrates. In several well-studied systems, the biosynthetic enzymes are highly conserved across species, meaning the catalytic machinery has barely changed over millions of years. Meanwhile, the substrate peptides are hypervariable, mutating rapidly and diversifying into dozens or even hundreds of variants within a single organism’s genome.28Trends in Chemistry. Corepeptides: Pathways, Structures, and Their Significance This arrangement puts a premium on product diversity: a few versatile enzymes can churn out a wide repertoire of chemically distinct products, giving the organism a broad chemical toolkit without needing a proportional expansion in its enzyme-coding genes. It is an elegant evolutionary strategy, something like having one highly flexible factory that accepts many different raw materials and produces a wide range of outputs.
This flexibility also means that natural genome databases contain an enormous reservoir of untapped chemical diversity. Every new microbial genome sequenced potentially harbors novel core peptide sequences that existing, well-characterized enzymes could process into new molecules. The combination of genome mining, machine learning classification, and heterologous expression in tractable host organisms is turning that potential into reality, one peptide at a time.